Benzinga's Bulls and Bears: AMC, Apple, Philip Morris, Ford and Elon Musk's "Demon Mode"
Benzinga has reviewed the outlook for many investors' favorite stocks over the past week. Here's a look at some of our top stories.
The S&P 500 and the Dow Jones Industrial Average (DJIA) ended the week on a high note, with gains of 0.69% and 2.08% respectively, marking the second consecutive week of gains. The DJIA also recorded its 10th consecutive positive session on Friday, its longest winning streak since August 2017.
However, the Nasdaq fell 0.57% during the week and the market saw increased volatility as approximately $2.3 trillion in derivative options contracts expired. Looking ahead, traders are cautious due to the upcoming Federal Open Market Committee meeting, with expectations of a 0.25% rate hike already priced in, but uncertainty remains over the Fed's future plans.
Benzinga provides daily reports on the most popular stocks with investors. Here are some of the most bullish and bearish messages from the past week that are worth revisiting.
BullsIn "Why AMC Stock Is Trading Higher And APE Units Trading Lower", AJ Fabino writes that AMC Entertainment Holdings Inc. AMC shares surged after a Delaware court blocked the company's decision to convert its APE Preferred Stock into common stock, which would have diluted retail investor holdings, while AMC Entertainment Hldg Pref Equity Units APE shares fell sharply.
'Tobacco giant Phillip Morris to buy marijuana inhaler producer for $650 million, seeking FDA approval', by Nina Zdinjak, reports that the Premier of Philip Morris International Inc. is set to acquire Israeli medical technology company Syqe Medical for $650 million, with the deal including a $130 million investment to secure FDA approval for the medical marijuana inhaler from Syqe.
"Apple analyst Expects Stock to Hit $ 210 ON 2024 Earnings projections, iPhone Delay", by Priya Nigam, notes that, despite a low demand and potential delays for the iPhone 15A, a Bofa Securities analyst maintains a neutral note on Apple Inc. Aappl, passing the price of the price of 190 $ projected states for 2024.
For other bullish calls from the past week, check out the following:
BlackRock CEO Larry Fink Reveals Stunning Demand for Bitcoin and Ethereum Among Gold Investors: 'We're Seeing More and More Interest'
Tesla analyst explains why Q2 margin squeeze shouldn't be a problem for the stock: 'The long-term question is...'
Netflix's password crackdown gamble pays off: Co-CEO says 'Retention is pretty good in essence'
The BearsIn "Elon Musk can be destructive, says the biographer who followed the billionaire for 3 years", Adam Eckert writes that Walter Isaacson, bi...
Benzinga has reviewed the outlook for many investors' favorite stocks over the past week. Here's a look at some of our top stories.
The S&P 500 and the Dow Jones Industrial Average (DJIA) ended the week on a high note, with gains of 0.69% and 2.08% respectively, marking the second consecutive week of gains. The DJIA also recorded its 10th consecutive positive session on Friday, its longest winning streak since August 2017.
However, the Nasdaq fell 0.57% during the week and the market saw increased volatility as approximately $2.3 trillion in derivative options contracts expired. Looking ahead, traders are cautious due to the upcoming Federal Open Market Committee meeting, with expectations of a 0.25% rate hike already priced in, but uncertainty remains over the Fed's future plans.
Benzinga provides daily reports on the most popular stocks with investors. Here are some of the most bullish and bearish messages from the past week that are worth revisiting.
BullsIn "Why AMC Stock Is Trading Higher And APE Units Trading Lower", AJ Fabino writes that AMC Entertainment Holdings Inc. AMC shares surged after a Delaware court blocked the company's decision to convert its APE Preferred Stock into common stock, which would have diluted retail investor holdings, while AMC Entertainment Hldg Pref Equity Units APE shares fell sharply.
'Tobacco giant Phillip Morris to buy marijuana inhaler producer for $650 million, seeking FDA approval', by Nina Zdinjak, reports that the Premier of Philip Morris International Inc. is set to acquire Israeli medical technology company Syqe Medical for $650 million, with the deal including a $130 million investment to secure FDA approval for the medical marijuana inhaler from Syqe.
"Apple analyst Expects Stock to Hit $ 210 ON 2024 Earnings projections, iPhone Delay", by Priya Nigam, notes that, despite a low demand and potential delays for the iPhone 15A, a Bofa Securities analyst maintains a neutral note on Apple Inc. Aappl, passing the price of the price of 190 $ projected states for 2024.
For other bullish calls from the past week, check out the following:
BlackRock CEO Larry Fink Reveals Stunning Demand for Bitcoin and Ethereum Among Gold Investors: 'We're Seeing More and More Interest'
Tesla analyst explains why Q2 margin squeeze shouldn't be a problem for the stock: 'The long-term question is...'
Netflix's password crackdown gamble pays off: Co-CEO says 'Retention is pretty good in essence'
The BearsIn "Elon Musk can be destructive, says the biographer who followed the billionaire for 3 years", Adam Eckert writes that Walter Isaacson, bi...
What's Your Reaction?
